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esponsibility of InstAbstract Triptolide is a diterpenoid compound that inhibits the inﬂammation of rheumatoid arthritis (RA).
However, the use of triptolide is limited due to its strong gastrointestinal toxicity. The purpose of this work was
to develop a transdermal delivery system for triptolide to reduce this toxicity. A microemulsion-based hydrogel
(MBH) was prepared from the combination of Gemseal 40-oleic acid as oil phase, Tween 80-labrasol as
surfactant, anhydrous ethanol as co-surfactant, water as aqueous phase and Poloxamer 407 as hydrogel matrix.
Rheological measurements, environmental scanning electron microscopy (ESEM) and transdermal experiments
in vitro were used to characterize triptolide-loaded and blank MBH preparations. The effects of Poloxamer 407
and triptolide on the rheological properties and microstructures of the MBH were determined. Transparent and
homogeneous MBH could only be formed when the concentration of Poloxamer 407 in the selected O/W
microemulsion was in the range of 14.0–16.0% (w/w). When the concentration of Poloxamer 407 increased, the
rheological properties such as the yield stresses (sy), storage and loss moduli (G′, G″) of the formulations
increased, and the network structures became more compact. The addition of triptolide did not change the
interconnected network structures of the MBH preparations. MBH preparations afford a better sustained release
proﬁle when compared to microemulsions, a ﬁnding conﬁrmed by an in vitro permeation test in mice. MBH
appears to be a promising vehicle for transdermal delivery of triptolide.
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Triptolide, which possesses potent anti-inﬂammatory and immuno-
suppressive properties, is one of the major active components in the
Chinese herbal remedy Tripterygium wilfordii Hook F (TWHF)1–4.
Triptolide has been reported to be therapeutically efﬁcacious in the
treatment of rheumatoid arthritis (RA)5–7, but the strong toxicity of
triptolide towards the gastrointestinal, hepatic, renal and reproduc-
tive systems has restricted its oral application to a great extent8,9.
Triptolide also has a narrow therapeutic window, with an effective
dose is nearly equal to its toxic dose10. To overcome these
disadvantages, chemical modiﬁcation and biotransformation of
triptolide has been investigated11–13. In addition, transformation of
the dosage form has also been explored14,15, and a transdermal drug
delivery preparation of triptolide, using a triptolide-loaded micro-
emulsion has been developed by our laboratory16.
A microemulsion is deﬁned as an oil/water (O/W) or water/oil
(W/O) emulsion producing a transparent product which has a
droplet size from 10 to 100 nm and does not coalesce17,18.
Microemulsions are composed of oil phase, surfactant, cosurfac-
tant and an aqueous phase at appropriate ratios19–21. Microemul-
sions have several speciﬁc physicochemical properties such as
transparency, optical isotropy, low viscosity and thermodynamic
stability20–23, and are a promising route of drug administration in
transdermal applications. However, the application of most micro-
emulsions, especially in the pharmaceutical industry may be
limited due to their inconvenient application, which is caused by
their extraordinary low viscosity. In order to improve the viscosity
of a preparation, hydrogel matrixes such as Carbomer 940,
Poloxamer 188, Poloxamer 407, xanthan gum and carrageenan
have been utilized to form MBH, which are more suitable for
transdermal applications as compared to microemulsions.
In the past few years a number of studies have been conducted
on the microstructure of MBH24–27. Usually, small-angle neutron
scattering28–30, electro-paramagnetic resonance31 and rheological
measurements32–34 were applied to characterize MBH microstruc-
ture. A rheological method has been employed in this study along
with ESEM to determine the dynamic and static macroscopic
properties and microstructure of our preparations.
In this study, MBH was formed by an O/W microemulsion,
which was composed of Tween 80-labrasol/Gemseal 40-oleic acid/
anhydrous ethanol/water, and Poloxamer 407. The rheometer and
ESEM were applied to study the effect of Poloxamer's concentra-
tion on the properties of the MBH and ﬁnd the best concentration
for preparation of a MBH with good viscoelasticity and compact
microstructure. We further investigated the effect of triptolide's
addition on the properties of the MBH. Based on these results, the
percutaneous penetration rates of microemulsion and MBH were
evaluated.2. Materials and methods
2.1. Materials
Triptolide was supplied by Fujian Hantang Group Co., Ltd.
(Fuzhou, China). Oleic acid (OA) was purchased from Xilong
Chemical Factory (Shantou, China). Gemseal 40 was purchased
from Shanghai Zhirou Chemical Co., Ltd. (Shanghai, China).
Polysorbate 80 (Tween 80) was procured from Zhejiang Clear
Pure Chemicals Co., Ltd. (Wenzhou, China). Caprylocaproyl
macrogolglycerides (Labrasol) was a kind gift from Gattefossé(France). Ethanol was purchased from Sinopharm Chemical
Reagent Co., Ltd. (Shanghai, China). All other chemicals and
solvents were of analytical reagent grade or chromatography
reagent grades.
2.2. Preparation of microemulsion
Formation of a triptolide-loaded microemulsion was based on our
previous study and was composed of OA-Gemseal 40 (4:6, 7.8%,
w/w), Labrasol-Tween 80 (4:1, 16.3%, w/w), ethanol (8.1%, w/w)
and water (67.8%, w/w)16. The method of preparation is as
follows: OA, Gemseal 40, Labrasol, Tween 80, ethanol and
triptolide were ﬁrst mixed together, and then water was added
into the above mixture drop by drop with magnetic stirring at
ambient temperature. After the resulting system was equilibrated
with gentle magnetic stirring for 30 min, a microemulsion contain-
ing triptolide was obtained.
2.3. Preparation of MBH
Poloxamer 407 was chosen as hydrogel matrix based on previous
experiments. Triptolide-loaded MBH was prepared according to a
method described by Chen et al.35. Poloxamer 407 was combined
with differing volumes of a triptolide-loaded microemulsion for
24 h to yield highly viscous solutions (MBH). The concentration
of Poloxamer 407 in these MBH preparations was 12%, 13%,
14%, 15%, 16%, 17% and 18% (w/w).
2.4. Rheological measurements
The rheological properties of the MBH samples were measured
with Anton Paar MCR101 Rheometer (Anton Paar Company,
Australia) at 3070.1 1C. The cone angle was 0.51 and the cone
diameter was 20 mm. The sample thickness in the middle of the
sensor was 1.0 mm. In oscillation experiments, a small amplitude
oscillation mode of frequency sweep was used, and a 1-Hz ﬁxed
frequency was adopted when the measurements of storage
modulus G′ and loss modulus G″ was determined over a stress
sweep between 3 and 500 Pa. In addition, the area of the
thixotropic loop was measured while the shear velocity varied
from 2 to 50/s and then back to 2/s. Moreover, the apparent
viscosity of samples was investigated while the shearing rate
varied from 1 to 200/s26,36,37. Finally, we determined the linear
viscoelastic area and the best concentration of Poloxamer 407. The
effects of triptolide addition on the rheological properties of MBH
were also determined.
2.5. ESEM observations
Samples were imaged using an ESEM (Quanta 200F, FEI, USA).
The beam energy was 30 kV and signals were collected using a
gaseous secondary electron detector (GSED). Water vapor was
used as the imaging gas with constant pressure of approximately
1000 Pa. The temperature was maintained at 25 1C during the
experiment. All samples were enlarged 5000 by the ESEM for
visualization before and after the addition of triptolide.
2.6. Skin irritation study
The skin irritation potential of triptolide-loaded MBH was con-
ducted in rabbits. The backs of rabbits (2.0–2.5 kg, Experimental
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Medicine, Jiangxi, China), were clipped free of fur with scissors
24 h prior to application of a patch. Just prior to the test, the
rabbits were randomly divided into two groups, one intact-skin
group and one skin-injury group, obtained by scarifying intact skin
until capillary hemorrhage. The two groups were subdivided into a
single-application subgroup and a multiple-applications subgroup.
The skin surface was further divided into four regions for
triptolide-loaded microemulsion, triptolide-loaded MBH, blank
microemulsion and blank MBH applications. For the single
application, 0.8 g of both preparations described above was
applied on the designated region (3 3 cm2). Polyethylene was
used to cover the applications and gauze tape was used to fasten
the polyethylene for 24 h until the drug was removed with warm
water. Inspection on the administration site for the presence of
erythema and edema began 1 h after removal of the drug. For
multiple applications, two preparations were applied on the same
skin regions for 6 h and 1 h after removal of the drug, then the
sites were assessed for signs of skin irritation. The test procedure
was repeated for 6 consecutive days. The irritation scores of the
test area were determined by judging the extent of erythema and
edema according to the criteria proposed by Chen et al.38.
Erythema and edema were graded as follows: zero for no visible
reaction, one for slight reaction, two for moderate reaction, three
for severe reaction, and four for extremely serious reaction. The
total scores for the irritation test in each condition were calculated
using the following equation.
Average irritation score¼ (Erythema reaction score+Dropsy
reaction score)/Amount of animal
2.7. In vitro permeation studies
2.7.1. Preparation of skins
Male Kunming mice weighing 2072 g were purchased from the
Experimental Animal Center of Jiangxi University of TCM (Jiang
Xi, China) for the permeation studies. The protocol of the study
was approved by the Ethical Committee of Jiangxi University of
TCM. Skin was obtained from the abdominal region of mice after
removing hair carefully with scissors, and the subcutaneous fat and
connective tissue were trimmed after that. Then the excised skin
was washed with physiological saline solution and examined for
integrity. Afterwards, the skin was kept at −20 1C for a maximum
of 7 days before use.
2.7.2. In vitro permeation studies
This experiment was performed by using Franz diffusion cells at
3770.5 1C. The Franz diffusion cells have an effective diffusion
area of 0.64 cm2 and a receiving pool capacity of 5 mL. The
excised skin was mounted on the receptor chamber with
the subcutaneous side facing upwards into the donor chamber
and the dermal side facing downwards into the receptor chamber,
which was ﬁlled with 5 ml of 20% (v/v) alcohol in physiological
saline solution. One gram of microemulsion or MBH (containing
0.03% triptolide) was added to the donor chamber. The receptor
medium was stirred at 300 rpm throughout the experiment. 1 mL
of receptor medium was extracted at 2, 4, 6, 8, 10, 12, 24 h and
then the same volume of 20% (v/v) alcohol in physiological saline
solution was immediately added into the receptor chamber. All
samples were ﬁltered through a 0.22 μm pore size cellulose
membrane ﬁlter and analyzed by HPLC. All experiments were
performed in triplicate.2.8. HPLC analysis of triptolide
The amount of permeated triptolide was determined by HPLC
using Agilent 1200 series consisting of a quaternary pump,
autosampler, diode-array detector and workstation. The column
was an ODS-2 HYPERSIL column (250 mm 4.6 mm, 5 μm).
The elution was performed at 35 1C and the mobile phase was a
methanol-water (45:55, v/v) mixture with a ﬂow rate of 1.0 mL/min.
The detection wavelength was monitored at 218 nm and the
retention time was 7.4 min. The assay was linear (r2¼0.9999) over
a concentration range of 0.3–30 μg/mL. The detection limit of this
method was 0.1 μg/mL. The RSD value for precision was below
0.5% and the percentage recoveries ranged 99.0–101.0%. No
interference of the other formulation components was observed.3. Results and discussion
3.1. Preparation of MBH
In order to obtain microemulsions with high drug-loading rate and
high permeability, a pseudo-ternary phase diagram and conductiv-
ity determination was utilized from our previous study. The
optimized formulation consisted of oil (7.8%, w/w), surfactant
(16.3%, w/w), co-surfactant (8.1%, w/w) and water (67.8%, w/w).
After addition of this microemulsion to Poloxamer 188, Poloxamer
407, sodium carboxyl methyl cellulose (CMC-Na), HPMC K4m,
HPMC E4m, Carbomer 934, Carbomer 940 or Carbomer 941
matrices for 24 h, only the Poloxamer viscous solutions remained
clear. One possible reason is that the Poloxamer 188 and
Poloxamer 407 matrices were not dissociated from the hydrated
state by surfactant and co-surfactant in the microemulsion, and had
no signiﬁcant inﬂuence on the formation of MBH. However, the
viscosity of microemulsion-Poloxamer 188 mix was too low and
so the Poloxamer 407 was chosen for further research.3.2. Rheological measurements
In the oscillation experiment, if the modulus of energy G′ was
found to be one order higher than loss modulus G′′ and this
condition held without intersection in the linear scope, which was
a typical characteristic of a gel, we concluded that a gel network
had formed. Moreover, a wider linear viscoelastic region usually
indicates a more compact gel network structure, which shows that
the sample could bear stronger elastic behavior and external
stress39,40. In order to characterize the LVE-R of the preparations
directly, the data of terminal shear stress of LVE-R were
determined and are given in Table 1.
Fig. 1A and B illustrate the values of G′ and G″ as a function of
the stress at 1.0 Hz. When the concentration of Poloxamer 407 was
lower than 14.0% (w/w), the values of G″ were higher than that of
G′ in the investigated stress range, and there was no linear
viscoelastic region, which suggested that the viscous properties
of the sample were more evident than the elastic properties. The
results indicate that the systems were colloidal. When the
concentration of Poloxamer 407 was between 14.0% (w/w) and
16.0% (w/w), the values of G′ were higher than G″ while shear
stress was below or equal to critical stress value and the values of
G′ were lower than G″ while shear stress was above critical stress.
An evident linear viscoelastic region could be found in this
Figure 1 Rheological images of (A) Blank MBH with different concentrations (12–18%) of Poloxamer 407 and (B) triptolide-loaded MBH with
different concentrations (14–16%) of Poloxamer 407.
Table 1 Terminal shear stress of LVE-R of blank MBH containing different concentrations of
Poloxamer 407.
Concentration of Poloxamer 407 (%) Terminal shear stress of LVE-R (Pa)
12 6.15
13 6.79
14 39.26
15 129.50
16 247.61
17 224.72
18 213.39
L. Chen et al.188concentration range. This indicated that the structure of gel
network had formed. In order to characterize the LVE-R of blank
preparations directly, the terminal shear stress data for LVE-R
were determined and are shown in Table 1. It can be clearly seen
that the system in which the concentration of Poloxamer 407 was
16% (w/w) was already at saturation point. Since all the water and
Poloxamer 407 had taken part in the formation of this saturated
sample, the viscoelastic properties were strongest and critical
stresses were maximum, which means that the system would not
be easily destroyed by external force. When the concentration of
Poloxamer 407 was higher than 16.0% (w/w), the values of G′ and
G″ were respectively about one to two orders of magnitude higher
than those of other systems in the investigated stress range,
indicating that the system became more solid-like at higher
concentration of Poloxamer 407.
Fig. 2A shows the apparent viscosity of the two MBH
preparations containing 15% Poloxamer 407. It was found that
the apparent viscosity of triptolide-loaded MBH was markedly
lower than that of blank MBH preparation. Hence, the addition of
triptolide decreased the viscosity of MBH. Further information
gained on the thixotropy of the two MBH preparations is shown in
Fig. 2B. The results of blank and triptolide-loaded MBH prepara-
tions were 3245.37 Pa/s and 3763.47 Pa/s, respectively. The
addition of triptolide affected the interconnected network to anoticeable extent, but this did not damage the stability of this
structure.3.3. ESEM observations
In this study, ESEM was used to observe the formation and
interconnected network structures of the MBH preparations. Fig. 3
shows ESEM images of the blank MBH preparation with different
concentrations of Poloxamer 407 (Fig. 3A–C) and the triptolide-
loaded MBH preparation with 16% (w/w) Poloxamer 407
(Fig. 3D).
Fig. 3A shows that the network structures of the O/W
microemulsion containing 13% (w/w) Poloxamer 407 had not
been formed completely, and that the system was still loose and
collosol. We found that as the concentration of Poloxamer 407
increased, the whole microemulsion would contribute to the
formation of the hydrogel. When the concentration of Poloxamer
407 was 14% (w/w), the interconnected network structures had
been formed. By comparison, the network structures of systems
containing 16% (w/w) Poloxamer 407 (Fig. 3B) were more
compact and the rheological measurement revealed that the
dynamic viscoelasticity of this system was strongest. When the
concentration of Poloxamer 407 increased to 17% (w/w) (Fig. 3C),
Figure 2 (A) Image of apparent viscosity study on blank MBH and triptolide-loaded MBH and (B) Image of thixotropy study on blank MBH and
triptolide-loaded MBH.
Figure 3 ESEM images of blank MBH with 13% (A), 16% (B), 17% (C) Poloxamer 407 and triptolide-loaded MBH with 16% Poloxamer (D).
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of incomplete swelling of the matrix at this concentration.
Fig. 3D shows the effect of triptolide on the microstructure of
MBH. The concentration of triptolide was ﬁxed at 0.03% (w/w)
and the concentration of Poloxamer 407 was 13%, 14%, 15%,16%, 17%, 18% (w/w). Compared to the blank MBH preparations,
the interconnected network structures of triptolide-loaded MBH
preparations were less well deﬁned. However, when the concentration
of Poloxamer 407 was 16% (w/w), the network structures of
systems were most compact.
Table 2 Average response scores of skin irritation for single application (n¼4).
Group Preparation Average score
1 h 24 h 48 h 72 h
Normal skin Loaded microemulsion 0.25 0.00 0.00 0.00
Loaded MBH 0.00 0.00 0.00 0.00
Blank microemulsion 0.00 0.00 0.00 0.00
Blank MBH 0.00 0.00 0.00 0.00
Damaged skin Loaded microemulsion 0.50 0.25 0.00 0.00
Loaded MBH 0.25 0.00 0.00 0.00
Blank microemulsion 0.25 0.00 0.00 0.00
Blank MBH 0.00 0.00 0.00 0.00
Table 3 Average response scores of skin irritation for multiple application (n¼4).
Group Preparation Average score
1 h 24 h 48 h 72 h
Normal skin Loaded microemulsion 0.25 0.25 0.00 0.00
Loaded MBH 0.00 0.00 0.00 0.00
Blank microemulsion 0.25 0.00 0.00 0.00
Blank MBH 0.00 0.00 0.00 0.00
Damaged skin Loaded microemulsion 0.75 0.50 0.25 0.00
Loaded MBH 0.50 0.25 0.00 0.00
Blank microemulsion 0.50 0.25 0.00 0.00
Blank MBH 0.25 0.00 0.00 0.00
L. Chen et al.1903.4. Skin irritation study
The results of skin irritation test are shown in Tables 2 and 3. On
the basis of Chen et al.38 where scores of o0.49 indicated no
irritation, 0.5–2.99 indicated slight irritation, 3–5.99 indicated
moderate irritation, and 6–8 indicated severe irritation. The tested
microemulsions and MBH preparations had no irritation on intact
skin after a single application or multiple applications. However,
slight skin irritation could be observed on injured skins after single
application or multiple applications of microemulsion. We attrib-
uted this result to a change in the microemulsion after adding
Poloxamer 407. In addition, the formed network structures and
increased viscosity may decrease the contact between skin and
microemulsion. Therefore, irritation by the MBH preparations was
much weaker, which was also shown by the blank microemulsion
and MBH preparation.Figure 4 Percutaneous permeation proﬁles of triptolide from the
microemulsion and MBH (Mean7SD; n¼5).3.5. In vitro permeation studies
Mouse skin has been used to study skin permeation of triptolide in
microemulsions and MBH preparations24. To ensure stable collec-
tion conditions, 20% (v/v) alcohol in physiological saline solution
was used as receptor ﬂuid. The transdermal permeation proﬁles
were typical steady-state proﬁles with a lag time (Fig. 4).
Table 4 shows that the cumulative amount of triptolide obtained
from the microemulsion was 355.479.9 μg/cm2, which was 3.4
times that of the MBH preparation at 24 h (104.4712.4 μg/cm2)
after application. The percutaneous absorption rate (Js, μg/(cm2 ·h)) of microemulsion was 3.6 times that of MBH, which showed
that addition of Poloxamer 407 to a microemulsion could decrease
the permeability of triptolide markedly. This may be attributed to
the formation of interconnected network structures and increased
viscosity41,42. Therefore, it can be concluded that the addition of
Poloxamer 407 into the microemulsion should delay drug release.
The MBH preparation containing 14–16% (w/w) Poloxamer
407 with suitable viscosity was used to deliver triptolide for
transdermal administration. In this study, the optimal concentration
of Poloxamer 407 was established. The addition of triptolide
Table 4 Percutaneous permeation analysis of triptolide from the microemulsion and MBH (n¼5).
Formulation Q24 (μg/cm2) Fitting equation Js (μg/(cm2 .h))
Microemulsion 355.479.9 Y¼16.632X−39.445 16.632
MBH 104.4712.4 Y¼4.5568X−4.3117 4.5568
Triptolide-loaded microemulsion-based hydrogels: physical properties and percutaneous permeability 191to MBH weakened the interconnected network structures of the
system to a certain extent, but the networks were not destroyed.
The results of the in vitro permeation test in mice showed that
MBH and microemulsion both facilitate the permeation of
triptolide. It can be concluded that MBH provides strong perme-
ability with low irritation and should prove to be a promising
transdermal drug delivery system.Acknowledgments
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